Purchase Order 140G0225P0059
Award Date
5/15/25
Potential Completion Date
5/14/28
Potential Value
$14K
Federal Agency
Office of Acquisitions and Grants
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lansing, MI 48911, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Smithsonian Institution, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract, valued at $17,236.09, is for the provision of scientific supplies and laboratory equipment to support the agency's research activities. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, and academics, has previously held prime and subcontracts with various...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of Veterans...
This is a $14,288 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V. The contract has a period of performance from April 1, 2025 to March 31, 2026 for Qiagen to provide laboratory services under the IP0023 Statement of Work. No set-aside designation was used. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, and other applications. The company...
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,060.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, for maintenance on laboratory equipment. The contract has a completion date of June 30, 2023 and was awarded on July 1, 2018. Qiagen has provided a range of goods and services to support federal...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...